Therapeutic insights into increasing HDL levels in Cardiovascular patients: Protein Arginine N-Methyltransferase (PRMT4) increases HDL-C via up regualtion of its target gene, 29/September/2014, 05.39 am

Therapeutic insights into increasing HDL levels in Cardiovascular patients: Protein Arginine N-Methyltransferase (PRMT4) increases HDL-C via up regualtion of its target gene, 29/September/2014, 05.39 am

Therapeutic insights into increasing HDL levels in Cardiovascular patients: Protein Arginine N-Methyltransferase (PRMT4) increases HDL-C via up regualtion of its target gene, 29/September/2014, 05.39 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Therapeutic insights into increasing HDL levels in Cardiovascular patients: Protein Arginine N-Methyltransferase (PRMT4) increases HDL-C via up regualtion of its target gene, 29/September/2014, 05.39 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that PRMT4, by increasing the expression of its target gene, it may decrease HDL-C levels. Thereby, it may increases the chances of developing cardiovascular disorders. Thus, this study suggests that pharmacological formulations encompassing “PRMT4  activators may be used to increase HDL-C levels.